Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy (IMPACTonIMT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01291641
Recruitment Status : Completed
First Posted : February 8, 2011
Last Update Posted : April 26, 2017
Korea Otsuka Pharmaceutical Co., Ltd.
Information provided by (Responsible Party):
Byung-Hee Oh, Seoul National University Hospital

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2016
  Actual Study Completion Date : March 2017
Publications of Results: